(Q34484296)

2 August 2017

The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model (English)

1 reference

2 August 2017

0 references

chronic fatigue syndrome

1 reference

Galama JM

3

0 references

author name string

Vercoulen JH

1

1 reference

2 August 2017

Swanink CM

2

1 reference

2 August 2017

Fennis JF

4

1 reference

2 August 2017

Jongen PJ

5

1 reference

2 August 2017

Hommes OR

6

1 reference

2 August 2017

van der Meer JW

7

1 reference

2 August 2017

Bleijenberg G

8

1 reference

2 August 2017

1 December 1998

1 reference

Journal of Psychosomatic Research

2 August 2017

1 reference

2 August 2017

45

1 reference

2 August 2017

6

1 reference

2 August 2017

507-517

1 reference

Cognitive behaviour therapy in chronic fatigue syndrome

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Chronic fatigue syndrome: a cognitive approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

The psychiatric status of patients with the chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Dimensional assessment of chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Prognosis in chronic fatigue syndrome: a prospective study on the natural course

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Longitudinal study of outcome of chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Chronic fatigue syndrome: a follow up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Chronic fatigue: risk factors for symptom persistence in a 2 1/2-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Fatigue in Multiple Sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Mania and recovery from chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

An Inventory for Measuring Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Follow up of patients presenting with fatigue to an infectious diseases clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

Multiple sclerosis: the impact of physical impairment and cognitive dysfunction on social and sparetime activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2898%2900023-3

10.1016/S0022-3999(98)00023-3

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference